These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29690585)

  • 21. Substrate Analogues for the Enzyme-Catalyzed Detoxification of the Organophosphate Nerve Agents-Sarin, Soman, and Cyclosarin.
    Bigley AN; Harvey SP; Narindoshvili T; Raushel FM
    Biochemistry; 2021 Sep; 60(38):2875-2887. PubMed ID: 34494832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced degradation of chemical warfare agents through molecular engineering of the phosphotriesterase active site.
    Hill CM; Li WS; Thoden JB; Holden HM; Raushel FM
    J Am Chem Soc; 2003 Jul; 125(30):8990-1. PubMed ID: 15369336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational enzymology for degradation of chemical warfare agents: promising technologies for remediation processes.
    de Castro AA; Assis LC; Silva DR; Corrêa S; Assis TM; Gajo GC; Soares FV; Ramalho TC
    AIMS Microbiol; 2017; 3(1):108-135. PubMed ID: 31294152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient Surface Display of Diisopropylfluorophosphatase (DFPase) in E. coli for Biodegradation of Toxic Organophosphorus Compounds (DFP and Cp).
    Latifi AM; Karami A; Khodi S
    Appl Biochem Biotechnol; 2015 Oct; 177(3):624-36. PubMed ID: 26239441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.
    Briseño-Roa L; Timperley CM; Griffiths AD; Fersht AR
    Protein Eng Des Sel; 2011 Jan; 24(1-2):151-9. PubMed ID: 21037279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evolution of phosphotriesterase for decontamination and detoxification of organophosphorus chemical warfare agents.
    Bigley AN; Raushel FM
    Chem Biol Interact; 2019 Aug; 308():80-88. PubMed ID: 31100274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In search of a catalytic bioscavenger for the prophylaxis of nerve agent toxicity.
    diTargiani RC; Chandrasekaran L; Belinskaya T; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):349-54. PubMed ID: 20176006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural characterization of the catalytic calcium-binding site in diisopropyl fluorophosphatase (DFPase)--comparison with related beta-propeller enzymes.
    Blum MM; Chen JC
    Chem Biol Interact; 2010 Sep; 187(1-3):373-9. PubMed ID: 20206152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Enzymatic detoxication of organophosphorus insecticides and nerve gases in primates].
    Losch H; Losch K; Haselmeyer KH; Chemnitius JM; Zech R
    Arzneimittelforschung; 1982; 32(12):1523-9. PubMed ID: 6297513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probing the Suitability of Different Ca
    Zlobin A; Diankin I; Pushkarev S; Golovin A
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in amino acid residues in the binding pockets dictate substrate specificities of mouse senescence marker protein-30, human paraoxonase1, and squid diisopropylfluorophosphatase.
    Belinskaya T; Pattabiraman N; diTargiani R; Choi M; Saxena A
    Biochim Biophys Acta; 2012 May; 1824(5):701-10. PubMed ID: 22401958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents.
    Vitorović-Todorović MD; Worek F; Perdih A; Bauk SĐ; Vujatović TB; Cvijetić IN
    Chem Biol Interact; 2019 Aug; 309():108714. PubMed ID: 31228470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective hydrolysis of organophosphate nerve agents by the bacterial phosphotriesterase.
    Tsai PC; Bigley A; Li Y; Ghanem E; Cadieux CL; Kasten SA; Reeves TE; Cerasoli DM; Raushel FM
    Biochemistry; 2010 Sep; 49(37):7978-87. PubMed ID: 20701311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Similar Active Sites and Mechanisms Do Not Lead to Cross-Promiscuity in Organophosphate Hydrolysis: Implications for Biotherapeutic Engineering.
    Purg M; Elias M; Kamerlin SCL
    J Am Chem Soc; 2017 Dec; 139(48):17533-17546. PubMed ID: 29113434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of organophosphorus hydrolysing enzymes on obidoxime-induced reactivation of organophosphate-inhibited human acetylcholinesterase.
    Herkenhoff S; Szinicz L; Rastogi VK; Cheng TC; DeFrank JJ; Worek F
    Arch Toxicol; 2004 Jun; 78(6):338-43. PubMed ID: 14985944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The DFPase from Loligo vulgaris in sugar surfactant-based bicontinuous microemulsions: structure, dynamics, and enzyme activity.
    Wellert S; Tiersch B; Koetz J; Richardt A; Lapp A; Holderer O; Gäb J; Blum MM; Schulreich C; Stehle R; Hellweg T
    Eur Biophys J; 2011 Jun; 40(6):761-74. PubMed ID: 21416312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrolysis of nerve gas by squid-type diisopropyl phosphorofluoridate hydrolyzing enzyme on agarose resin.
    Hoskin FC; Roush AH
    Science; 1982 Mar; 215(4537):1255-7. PubMed ID: 7058344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.